Skip to content

Auro Impex & Chemicals Ltd. (AUROIMPEX)

SME Cap

Industrials stocks · SME cap · NSE

Auro Impex & Chemicals Ltd. operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹38.55
-1.20 · -3.02%
Market cap ₹48.5 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm IST
Details
Quote19 Oct, 03:31 pm IST
Base fundamentals16 Oct 2026 · screener
Latest result25 May, 12:45 am IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags24 Apr 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

58Neutral

SMA20 +48.2% / mo · MACD −

Stock trend: 63
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

AUROIMPEXD candles · FIT view+15.8%
Latest close ₹38.55 on 2026-10-19
Bar
-7.6%
RSI
55
MACD hist
-0.44
52W pos
56%
Visible chart range
Candle interval
2026-10-19O ₹41.70H ₹41.70L ₹38.55C ₹38.55Vol 6,400 sh
₹22.69₹28.53₹34.38₹40.22₹46.06₹38.55VolRSIMACD2026-052026-072026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

AUROIMPEXNifty India ManufacturingNifty 500
-16%+18%+52%+86%20 Jul3 Sept19 Oct19 Oct 2026AUROIMPEX +52.4%Nifty India Manufactu… -5.8%Nifty 500 -5.6%
AUROIMPEX
+52.4%
Nifty 500
-5.6%
Nifty India Manufacturing
-5.8%
Vs Nifty 500
+57.9 pp
Chart stats
19 Oct 2026
From 52W high
-33.5%
₹58
52W range position
47%
₹21.3 - ₹58
ATR (14)
4.7%
₹1.8
Volume vs 20D
0.32x
Latest completed session
Avg traded value
₹0.1 Cr
20-session average
20D price channel
₹29.2 - ₹45
70.8% annualized volatility
Research snapshot

What the evidence says now

Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · FAIR VALUE
49

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Bad
0

Revenue -20.7% · PAT +0.0% YoY

Technical
Neutral
58

Price trend and sector-relative-strength timing.

Valuation
Legacy model
+71.3%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
65

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 31 Mar 2026

Bad · 0/100

Rev -21% YoY · PAT 0% YoY · margin expansion · operating leverage

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹115 Cr-20.7%-14.8%
EBITDA₹5 CrNDF+25.0%
Operating margin4.2%NDF+120 bps
PAT₹3 Cr+0.0%+50.0%
PAT margin2.6%NDF+113 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
11.70
P/B
0.95
EV/EBITDA
9.15
Market Cap
48.50Cr

Profitability

ROE
8.44%
ROCE
10.10%
ROA
3.67%
Dividend Y
—

Growth (CAGR)

Revenue 5Y
16.00%
EPS 5Y
16.00%
Revenue 3Y
3.00%
EPS 3Y
-11.00%

Balance Sheet

Debt/Equity
0.84
Interest Coverage
2.25×
Altman Z
3.74
Book Value
42.10

Cash Flow

FCF Yield
39.18%
FCF Positive Y
1/5
OCF
23.00 Cr
EPS TTM
3.41

Shareholding

Promoter Hold
71.78%
Promoter Pledge
0.00%
Momentum 52W
60%

Financial History

Updated 20/10/2026

Revenue

₹ Cr
Latest: 115-14.8% vs prev
0173.0Mar 2023: 110Sep 2023: 173Mar 2024: 145Sep 2024: 124Mar 2025: 139Sep 2025: 135Mar 2026: 115FY23Q2 23FY24Q2 24FY25Q2 25FY26

Net Profit

₹ Cr
Latest: 3.0+50.0% vs prev
03.0Mar 2023: 3.0Sep 2023: 3.0Mar 2024: 3.0Sep 2024: 2.0Mar 2025: 2.0Sep 2025: 2.0Mar 2026: 3.0FY23Q2 23FY24Q2 24FY25Q2 25FY26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 55. Wait for confirmation.

  • SMA20 rising (~32.5% over last month) — short-term momentum positive.
  • RSI(14) at 55 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 26% off 52W high · 81% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

67
RS percentile
Stage 3 Topping
1M return
+38.4%
3M return
+43.0%
6M return
+32.9%
1Y return
-31.2%
RS 1D
-1
RS 20D
+57
Sector rank
#2
Industry rank
#24
Stage evidence
  • 31.2% below the 52-week closing high after prior strength.
  • The 30-week proxy has stalled (+0.1% over 20 sessions).
  • Price has not yet confirmed a full Stage 4 downtrend.
50-DMA
price above
200-DMA
price above
Sector
leading
Industry
improving
Relative-strength line vs Nifty 500 (base 100)
207 observations
19 Oct 2026Value 82.42-2.40%
46617691106Sept 25Feb 26Jun 26Oct 2682
RS vs Nifty 50082

Valuation & peers

U-Score 49 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies

49U-SCORE
Deep Value

Fundamental score breakdown

U band · FAIR VALUE
Valuation26/30
Growth14/25
Quality1/20
Balance Sheet8/15
Cash Flow5/10
Piotroski
6/9 (+3)
Penalties
-8
Raw sum
49

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

49/100 · legacy band FAIR VALUE

Positive drivers

  • FCF yield is supportive at 39.2%.
  • Fair-value margin of safety is positive at 71.3%.
  • Valuation contributes 26/30 to the score.

Main drags

  • Penalty bucket subtracts 8 points.
  • Quality is weaker at 1/20; verify the latest quarterly trend.
  • Cash flow is weaker at 5/10; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
11.7
PB
0.9
EV/EBITDA
9.2
ROE
8.4%
ROCE
10.1%
FCF Yield
39.2%
Debt/Equity
0.8
MoS
+71.3%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
49
Previous: 49
Legacy U-Score band
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+71.3%
Previous: +71.3%

Score history

12 stored score snapshots. Latest stored move: +0 points.

20 Oct 2026
v4.3-runtime-valuation
49
49
49
49
49
49
49
49
49
49
49
49

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹56.83
+32.2% MoS
Growth-justified P/E
39.3
Growth-justified Value
₹134.01
+71.3% MoS
PEG
0.73

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
UNILEX
SME
Unilex Colours and Chemicals Ltd.
Specialty Chemicals
match 115
36
5.0
10.4%
+32%
WATCHLIST
SNEHAA
SME
Snehaa Organics Ltd.
Specialty Chemicals
match 115
77
5.6
24.2%
+87%
DEEP VALUE
MCON
SME
Mcon Rasayan India Ltd.
Specialty Chemicals
match 113
60
9.8
8.8%
+75%
UNDERVALUED
VSCL
SME
VADIVARHE SPECIALITY CHEMICALS LTD.
Specialty Chemicals
match 111
18
—
—
—
OVERVALUED
RITEZONE
SME
Rite Zone Chemcon India Ltd.
Specialty Chemicals
match 109
53
21.2
2.2%
+43%
FAIR VALUE

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

Auro Impex & Chemicals Ltd. operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
65Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 45th percentile of the scored universe and 44th percentile within Industrials. Main check: results consistency is weak at 49/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
1 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
45th percentile

overall median 67 · Industrials: 44th pctile, median 68 · SME: 56th pctile, median 64

Evidence depth
Financial-only

1 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
65
acceptable · profit to cash conversion
Balance sheet
73
acceptable · leverage and solvency
Discipline
50
watch · capital discipline
Results
49
watch · quarterly consistency

Trust positives

  • ▸Promoter holding is 71.6%.
  • ▸Promoter pledge is zero.
  • ▸FCF yield is 56.6%.
  • ▸OPM spread across recent quarters is 3%.

Trust risks

  • ▸2 latest quarters had PAT decline worse than 25% YoY.
  • ▸Only 1 years of positive FCF.
  • ▸ROCE trend is -3.2%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

6 shown
Annual reportSep 2026

Sep 2026 · General Updates 21 Aug - 33rd AGM on 12 Sep 2026; FY2025-26 annual report web link dispatched to shareholders.

Source: Nse

Open source ↗
Annual reportSep 2026

Sep 2026 · Shareholders meeting 20 Aug - 33rd AGM on 12 Sept 2026; annual report issued, with resolutions on directors, borrowings and share capital.

Source: Nse

Open source ↗
Annual reportSep 2026

Sep 2026 · Copy of Newspaper Publication 21 Aug - 33rd AGM on 12 September 2026; annual report and e-voting details published.

Source: Nse

Open source ↗
Announcement

Updates 19 Sep - Company clarifies recent share price movement, citing no pending material announcement.

Source: Nse

Open source ↗
Annual reportMar 2026

Mar 2026 · Annual Report 2026

Source: Nse

Open source ↗
Annual reportMar 2025

Mar 2025 · Annual Report 2025

Source: Nse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.